WallStSmart

McCormick & Company Incorporated (MKC)vsArcadia Biosciences Inc (RKDA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

McCormick & Company Incorporated generates 132131% more annual revenue ($6.84B vs $5.17M). MKC leads profitability with a 11.5% profit margin vs -98.0%. MKC earns a higher WallStSmart Score of 58/100 (C).

MKC

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 6.5Value: 7.3Quality: 4.8
Piotroski: 4/9Altman Z: 1.58

RKDA

Hold

37

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 5.0Quality: 5.3
Piotroski: 3/9Altman Z: -29.26
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MKCSignificantly Overvalued (-41.3%)

Margin of Safety

-41.3%

Fair Value

$49.93

Current Price

$52.78

$2.85 premium

UndervaluedFair: $49.93Overvalued

Intrinsic value data unavailable for RKDA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MKC2 strengths · Avg: 8.0/10
P/E RatioValuation
17.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

RKDA2 strengths · Avg: 9.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

EPS GrowthGrowth
28.5%8/10

Earnings expanding 28.5% YoY

Areas to Watch

MKC3 concerns · Avg: 4.0/10
PEG RatioValuation
1.934/10

Expensive relative to growth rate

Revenue GrowthGrowth
2.9%4/10

2.9% revenue growth

Altman Z-ScoreHealth
1.584/10

Distress zone — elevated risk

RKDA4 concerns · Avg: 2.5/10
Market CapQuality
$3.71M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-64.6%2/10

ROE of -64.6% — below average capital efficiency

Revenue GrowthGrowth
-15.3%2/10

Revenue declined 15.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : MKC

The strongest argument for MKC centers on P/E Ratio, Price/Book.

Bull Case : RKDA

The strongest argument for RKDA centers on Price/Book, EPS Growth.

Bear Case : MKC

The primary concerns for MKC are PEG Ratio, Revenue Growth, Altman Z-Score.

Bear Case : RKDA

The primary concerns for RKDA are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

MKC profiles as a value stock while RKDA is a turnaround play — different risk/reward profiles.

RKDA carries more volatility with a beta of 0.61 — expect wider price swings.

MKC is growing revenue faster at 2.9% — sustainability is the question.

MKC generates stronger free cash flow (458M), providing more financial flexibility.

Bottom Line

MKC scores higher overall (58/100 vs 37/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

McCormick & Company Incorporated

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

McCormick & Company is an American multinational food company that manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavoring products to retail outlets, food manufacturers, and foodservice businesses.

Arcadia Biosciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Arcadia Biosciences, Inc. is dedicated to developing various crop productivity traits primarily in hemp, wheat, and soybeans. The company is headquartered in Davis, California.

Visit Website →

Want to dig deeper into these stocks?